2017
DOI: 10.1097/sla.0000000000002023
|View full text |Cite
|
Sign up to set email alerts
|

Path From Predictive Analytics to Improved Patient Outcomes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
11
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 33 publications
(12 citation statements)
references
References 7 publications
1
11
0
Order By: Relevance
“…The real test of the value of a predictive model should not only be discrimination or calibration. The effects of specific applications of predictive models (eg, informed consent, shared decision-making, risk stratification) need to be rigorously evaluated in terms of their impact on patient outcomes and satisfaction [34].…”
Section: Discussionmentioning
confidence: 99%
“…The real test of the value of a predictive model should not only be discrimination or calibration. The effects of specific applications of predictive models (eg, informed consent, shared decision-making, risk stratification) need to be rigorously evaluated in terms of their impact on patient outcomes and satisfaction [34].…”
Section: Discussionmentioning
confidence: 99%
“…Within health care, early successes of PM and ML models have energized the community. 6 , 8 , 9 , 14–19 Despite this high level of enthusiasm about PM and ML, little is known about the barriers that health care organizations face when they attempt to leverage the emerging fields of PM and ML to optimize care. We hypothesize that AMCs, with their access to clinical and informatics pioneers and experts, might be in the best position to provide insights to the rest of the community on how to overcome these barriers.…”
Section: Introductionmentioning
confidence: 99%
“…In addition, by enabling the prediction of ASA-PS when it is not available and potentially improving the measure’s accuracy when ASA-PS is available, we also see our effort as an aid for other researchers and clinicians to build better risk prediction models. Further external validation of this model with non-ACS-NSQIP data will help define the minimal number of elements needed to predict ASA-PS and further refine predictive ability [26, 38, 39].…”
Section: Discussionmentioning
confidence: 99%